Secondary Outcomes
haze, uveitis, floaters
UVEITIS
Patients in the early vaccination group more frequently reported new onset of floaters as one of the reasons for symptomatic uveitis worsening (difference, 4.2% [95% CI, 1.7%-7.5%]). The ocular conditions, including changes in anterior chamber cells, vitreous haze, and BCVA from baseline to month 3, appeared similar between the 2 groups in the month 3 in-person evaluable population (